NEAT1 lncRNAの過剰発現は,幼児期B-ALLにおける短期的な進行と治療結果の低下につながる
Marieta Xagorari1, Antonios Marmarinos1, Dimitrios Doganis2
1Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 'P. & A. Kyriakou' Children's Hospital, Athens, Greece.
British journal of haematology
|September 1, 2025
まとめ
乳児期B細胞急性リンパ性白血病 (chB- ALL) 患者におけるNEAT1過剰発現は,進行の危険性が高く,生存率が低下することを予測する. この発見により,現在のマーカーを超えてリスクの階層化が改善され,治療結果が改善されます.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 幼児の急性リンパ性白血病 (chALL) は最も一般的な小児がんです.
- CHALLの正確なリスク分層と個別化された治療は,依然として重要な臨床的課題です.
- 長い非コーディングRNA (lncRNAs) は,がんの発達と進行における役割としてますます認識されています.
研究 の 目的:
- 幼児のB細胞前駆体ALL (chB-ALL) の診断と治療結果の予測におけるNEAT1 lncRNAの臨床的有用性を調査する.
- chB-ALL患者における疾患進行と生存の独立した予測因子としてNEAT1を評価する.
- 既知の臨床マーカーと比較して,NEAT1がリスクの階層化を改善するかどうかを評価する.
主な方法:
- chB-ALL患者からの骨髄サンプルにおけるNEAT1_ 1同型の定量化
- 生存分析は再発と死亡をエンドポイントとして用いる.
- 多変量分析と決定曲線分析により,予後値と臨床的有用性を評価する.
主要な成果:
- 診断時のNEAT1過剰発現は,chB- ALL患者における進行リスクの上昇 (HR=2. 957) と生存率の低下 (HR=5. 832) と有意に関連していた.
- NEAT1は独立した予測因子として機能し,白血球数,骨髄反応,最小残留疾患などの従来のマーカーを上回った.
- 決定曲線解析は,chB-ALLの予後に対するNEAT1の優れた臨床的純利益を確認した.
結論:
- NEAT1の過剰発現は chB-ALLの強力で独立した予後マーカーです.
- NEAT1は,よりパーソナライズされた治療戦略を可能にする,洗練されたリスクの階層化を可能にします.
- この発見は,小児のB細胞ALLの改善に重大な意味を持つ.
さらに関連する動画
関連する概念動画
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
03:18Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K